Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review

Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review

Context: Several liquid- and tissue-based biomarker tests (LTBTs) are available to inform the need for prostate biopsies and treatment of localised prostate cancer (PCa) through risk stratification, but translation into routine practice requires evidence of their clinical utility and economic impact...

Full description

Bibliographic Details
Main Authors: Koen Degeling, Amanda Pereira-Salgado, Niall M. Corcoran, Paul C. Boutros, Peter Kuhn, Maarten J. IJzerman
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:European Urology Open Science
Subjects:
Biomarker
Blood test
Budget impact
Cost
Cost-effectiveness
Health economics
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168321000586

Similar Items

Similar Items